Olfr703 Inhibitors
Olfr703, a member of the olfactory receptor family in Mus musculus (house mouse), plays a crucial role in the perception of smells. As a G-protein-coupled receptor (GPCR), it shares structural similarities with other neurotransmitter and hormone receptors. Olfr703 is known for its involvement in recognizing odorant molecules and initiating neuronal responses through G protein-mediated signal transduction. In the mouse genome, the olfactory receptor gene family, including Olfr703, represents the largest group of genes with a single coding-exon structure. The nomenclature assigned to olfactory receptor genes and proteins in mice is independent of other organisms, emphasizing their diversity and importance in the olfactory system.
Inhibition of Olfr703 can be achieved through various mechanisms, primarily focusing on indirect modulation due to the limited availability of direct inhibitors. Compounds such as Forskolin and SQ22536 can influence Olfr703 by regulating cyclic AMP (cAMP) levels, a critical component of olfactory receptor signaling. Additionally, inhibitors like Suramin and Propranolol, which affect GPCR signaling pathways, may indirectly impact Olfr703 function. Furthermore, targeting intracellular pathways associated with olfactory receptor function, such as the MAPK and PI3K/Akt pathways with compounds like U0126 and Wortmannin, respectively, can also lead to Olfr703 modulation. These inhibitors, while not directly proven for Olfr703, offer potential avenues for research into controlling olfactory receptor responses in mice. In conclusion, Olfr703 plays a pivotal role in the perception of odors in mice, being a member of the extensive olfactory receptor gene family. Inhibition of Olfr703 can be achieved indirectly through various chemical compounds that influence GPCR signaling, cAMP levels, and associated intracellular pathways. Further research is needed to explore the precise mechanisms of Olfr703 inhibition and their potential applications in understanding olfactory processes in mice.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Suramin sodium | 129-46-4 | sc-507209 sc-507209F sc-507209A sc-507209B sc-507209C sc-507209D sc-507209E | 50 mg 100 mg 250 mg 1 g 10 g 25 g 50 g | $152.00 $214.00 $728.00 $2601.00 $10965.00 $21838.00 $41096.00 | 5 | |
Suramin is a non-specific GPCR antagonist. It could potentially inhibit Olfr703 by interfering with GPCR signaling. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective phosphodiesterase 4 (PDE4) inhibitor. By regulating cAMP levels, it may indirectly influence Olfr703, which is involved in cAMP-mediated signal transduction. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a MEK1/2 inhibitor that affects the MAPK pathway. Olfr703 may be indirectly influenced as it interacts with downstream components of this pathway. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent PI3-kinase inhibitor. It may indirectly inhibit Olfr703 by affecting the PI3K/Akt pathway, which can be involved in olfactory receptor signaling. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 inhibits MEK1, a kinase in the MAPK pathway. Olfr703, connected to this pathway, may be indirectly modulated by this inhibitor. | ||||||
SQ 22536 | 17318-31-9 | sc-201572 sc-201572A | 5 mg 25 mg | $95.00 $363.00 | 13 | |
SQ22536 is an adenylate cyclase inhibitor, reducing cAMP levels. Olfr703, dependent on cAMP signaling, may be indirectly influenced by this compound. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3-kinase inhibitor, potentially affecting the PI3K/Akt pathway, which might indirectly modulate Olfr703, involved in cellular processes influenced by this pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 inhibits p38 MAPK, part of the MAPK pathway. Olfr703 may be indirectly affected due to its association with this pathway. | ||||||
Propranolol | 525-66-6 | sc-507425 | 100 mg | $180.00 | ||
Propranolol is a non-selective beta-blocker. It might indirectly affect Olfr703, as beta-adrenergic receptors are linked to GPCR signaling pathways that could interact with olfactory receptors. | ||||||